Literature DB >> 33950418

Minimising prescription errors-a quality improvement project in the ophthalmology department in a tertiary referral hospital.

Tulsi Changulani1, Mohammad Zuhair Mustafa2, Sanjana Ahuja3, Angela James2, Pankaj K Agarwal2.   

Abstract

PURPOSE: The aim of this quality improvement project was to look into the hospital prescriptions and to identify and record the type and number of errors, to implement measures to reduce the risk of these errors and then to reaudit to assess the impact of changes implemented.
METHODS: The initial audit was conducted prospectively over a eleven-week period. Prescriptions written by doctors of all grades and members of the staff, such as optometrists and nurses, were analysed. A glaucoma prescription guide along with more training at prescribing for doctors was introduced with a view to reducing these errors. A reaudit later demonstrated a significant reduction in these errors.
RESULTS: After the introduction of a glaucoma prescription guide and more training for all grades of staff members, prescription errors reduced to 73/2342 (3.1%). Reaudit showed a reduction in both prescription writing errors 50/73(68.4%) and drug-related errors 23/73(31.6%).
CONCLUSION: Prescription errors are avoidable. This audit demonstrated that providing an accessible, easy to read and understand glaucoma prescription guide in the outpatient department along with targeted training for medical staff in prescribing can help in minimising these errors and can lead to safer practice.

Entities:  

Keywords:  Drug errors; Glaucoma chart; Ophthalmology; Pharmacist; Prescription errors

Year:  2021        PMID: 33950418     DOI: 10.1007/s10792-021-01866-2

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  3 in total

1.  Corneal graft rejection in a child and inadvertent substitution of Tobrex for TobraDex.

Authors:  W S Potter; L B Nelson; I M Raber
Journal:  Ophthalmic Surg       Date:  1990-09

2.  Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.

Authors:  D W Bates; D J Cullen; N Laird; L A Petersen; S D Small; D Servi; G Laffel; B J Sweitzer; B F Shea; R Hallisey
Journal:  JAMA       Date:  1995-07-05       Impact factor: 56.272

3.  Systems analysis of adverse drug events. ADE Prevention Study Group.

Authors:  L L Leape; D W Bates; D J Cullen; J Cooper; H J Demonaco; T Gallivan; R Hallisey; J Ives; N Laird; G Laffel
Journal:  JAMA       Date:  1995-07-05       Impact factor: 56.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.